Abstract
The radiosynthesis and the radiopharmacological evaluation of pyrazolo steroid 2′-(4-fluorophenyl)-21-[ 18F]fluoro-20-oxo-11β,17α-dihydroxy-pregn-4-eno[3,2- c]pyrazole [ 18 F]-2 is described. The radiolabeling was accomplished in 3–4% decay-corrected radiochemical yield within 80 min at an specific radioactivity of 0.8–1.2 Ci/μmol. Biodistribution studies in male Wistar rats showed an initial brain uptake of 0.25 ± 0.03% ID/g after 5 min, which remained constant over 60 min. The radiopharmacological evaluation of compound [ 18 F]-2 was completed with autoradiography using rat brain sections and micro-PET imaging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
